Cohance Lifesciences Limited (NSE:COHANCE)
India · Delayed Price · Currency is INR 479.00
-9.20 (-1.88%)
May 11, 2026, 3:29 PM IST
Cohance Lifesciences Market Cap
Cohance Lifesciences has a market cap or net worth of 183.23 billion as of May 11, 2026. Its market cap has decreased by -38.38% in one year.
Market Cap
183.23B
Enterprise Value
185.10B
Revenue
10.79B
Ranking
n/a
PE Ratio
203.84
Stock Price
479.00
Market Cap Chart
Since March 9, 2020, Cohance Lifesciences's market cap has increased from 33.71M to 183.23B, an increase of 543,530.12%. That is a compound annual growth rate of 303.35%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 8, 2026 | 186.77B | -7.64% |
| Dec 31, 2025 | 202.22B | -30.24% |
| Dec 31, 2024 | 289.89B | 57.55% |
| Dec 29, 2023 | 184.00B | 46.05% |
| Dec 30, 2022 | 125.98B | 0.33% |
| Dec 31, 2021 | 125.56B | 9.05% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Mar 9, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Ipca Laboratories | 393.90B |
| Ajanta Pharma | 379.03B |
| Gland Pharma | 313.76B |
| Emcure Pharmaceuticals | 311.50B |
| Wockhardt | 261.04B |
| Piramal Pharma | 238.81B |
| NATCO Pharma | 210.40B |
| Eris Lifesciences | 192.03B |